Dexmedetomidine Premedication in Hypertensive Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

162

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

April 30, 2013

Study Completion Date

June 30, 2013

Conditions
Hypertension
Interventions
DRUG

Midazolam

Midazolam was calculated by actual body weight of patients that had been diluted with saline to 40 ml. It was administered 15 min before induction of anesthesia via intravenous infusion. at a dose of 0.025 mg.kg-1

DRUG

Dexmedetomidine

Dexmedetomidine was calculated by actual body weight of patients that had been diluted with saline to 40 ml. Dexmedetomidine was administered 15 min before induction of anesthesia via intravenous infusion. at a dose of 0.5 µg.kg-1

Trial Locations (1)

81620

Duzce University Medicine School, Anesthesiology and Reanimation Department, Düzce

All Listed Sponsors
lead

Duzce University

OTHER

NCT02058485 - Dexmedetomidine Premedication in Hypertensive Patients | Biotech Hunter | Biotech Hunter